These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 4109664)
1. [Immune reactions against human malignant tumors]. Kåresen R Tidsskr Nor Laegeforen; 1971 Dec; 91(35):2555-60. PubMed ID: 4109664 [No Abstract] [Full Text] [Related]
2. Effect of autoimmunization with irradiated tumour cells on specific cell-mediated immunity in patients with malignant melanoma. Currie GA Proc R Soc Med; 1972 Feb; 65(2):144-7. PubMed ID: 4563684 [No Abstract] [Full Text] [Related]
3. Some recent developments in human tumour immunology. The TH Folia Med Neerl; 1972; 15(6):279-90. PubMed ID: 4565658 [No Abstract] [Full Text] [Related]
5. Specific antibody activation of lymphocytes for cell-mediated cytotoxicity against cultured target cells. Takasugi M; Kinoshita K J Natl Cancer Inst; 1974 Dec; 53(6):1539-44. PubMed ID: 4474407 [No Abstract] [Full Text] [Related]
6. Studies on specificity of cell-mediated immunity to human tumors. Takasugi M; Mickey MR; Terasaki PI J Natl Cancer Inst; 1974 Dec; 53(6):1527-38. PubMed ID: 4140237 [No Abstract] [Full Text] [Related]
7. Anti-tumor immunoreactivity in patients with malignant melanoma. Nairn RC; Nind AP; Guli EP; Davies DJ; Little JH; Davis NC; Whitehead RH Med J Aust; 1972 Feb; 1(9):397-403. PubMed ID: 4554232 [No Abstract] [Full Text] [Related]
8. The immune reaction against malignant melanoma studied in a biopsy material. Kåresen R Acta Pathol Microbiol Scand A; 1974 Jan; 82(1):116-26. PubMed ID: 4133272 [No Abstract] [Full Text] [Related]
9. Cytotoxicity of lymphocytes to established cultures of human tumors: evidences for specificity. Sinkovics JG; Tebbi K; Cabiness JR Natl Cancer Inst Monogr; 1973 Jun; 37():9-18. PubMed ID: 4123456 [No Abstract] [Full Text] [Related]
10. Immunological aspects of malignant melanoma of the choroid. Rahi AH Trans Ophthalmol Soc U K (1962); 1973; 93(0):79-91. PubMed ID: 4602170 [No Abstract] [Full Text] [Related]
11. Host factors in human malignant melanoma. Lewis MG Pathol Annu; 1971; 6():171-95. PubMed ID: 4949366 [No Abstract] [Full Text] [Related]
12. Demonstration of antibodies against human malignant melanoma by immunofluorescence. Morton DL; Malmgren RA; Holmes EC; Ketcham AS Surgery; 1968 Jul; 64(1):233-40. PubMed ID: 4173159 [No Abstract] [Full Text] [Related]
15. In vivo and in vitro assays of cellular immunity to human tumor antigens. Herberman RB Fed Proc; 1973 Feb; 32(2):160-4. PubMed ID: 4120197 [No Abstract] [Full Text] [Related]
16. [Cytotoxic immunity indices of melanoma B16 growth in mice]. Korosteleva TA; Veresova OV Vopr Onkol; 1980; 26(1):67-70. PubMed ID: 7355591 [TBL] [Abstract][Full Text] [Related]
17. Proceedings: Tumour-specific antigens in melanoma. Lewis MG Proc Natl Cancer Conf; 1972; 7():77-83. PubMed ID: 4587663 [No Abstract] [Full Text] [Related]
18. Tumor-bound immunoglobulins: their possible role in circumventing antitumor immunity. Witz IP; Levy HJ; Keisari Y; Izsak FC Johns Hopkins Med J Suppl; 1974; 3():289-300. PubMed ID: 4214276 [No Abstract] [Full Text] [Related]
19. [Use of immunologic tests in cancerology]. Cerottini JC; Mach JP; Isliker H Helv Chir Acta; 1973 Dec; 40(5):551-9. PubMed ID: 4589041 [No Abstract] [Full Text] [Related]
20. In vitro demonstration of cell-mediated immunity to human brain tumors. Levy NL; Mahaley MS; Day ED Cancer Res; 1972 Mar; 32(3):477-82. PubMed ID: 4334410 [No Abstract] [Full Text] [Related] [Next] [New Search]